Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: An observational study

Matteo Filippini, Chiara Bazzani, Ennio Giulio Favalli, Antonio Marchesoni, Fabiola Atzeni, Piercarlo Sarzi-Puttini, Francesca Bobbio Pallavicini, Roberto Caporali, Roberto Gorla

Research output: Contribution to journalArticle

Abstract

This study aims to compare the efficacy and safety of anti-TNF agents in elderly (aged ≥65 years) and younger patients (aged 18-65 years) with active RA. The study involved 1,114 RA patients treated with anti-TNF drugs and followed-up for >6 months by LORHEN group, who were divided into two cohorts on the basis of their age (311 aged ≥65 and 803 aged

Original languageEnglish
Pages (from-to)90-96
Number of pages7
JournalClinical Reviews in Allergy and Immunology
Volume38
Issue number2-3
DOIs
Publication statusPublished - Apr 2010

Keywords

  • Adverse events
  • Elderly patients
  • Elderly-onset rheumatoid arthritis
  • LORHEN database
  • Younger-onset rheumatoid arthritis

ASJC Scopus subject areas

  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Efficacy and safety of anti-tumour necrosis factor in elderly patients with rheumatoid arthritis: An observational study'. Together they form a unique fingerprint.

  • Cite this